GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents.
Caitlyn Bradford, PharmD
Advertisement
Caitlyn Bradford, PharmD, is an assistant professor of clinical pharmacy at the Philadelphia College of Pharmacy at Sa
Articles by Caitlyn Bradford, PharmD
Advertisement
Latest Updated Articles
Advancements in FDA approvals for pediatric obesity treatmentPublished: July 14th 2023 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
2
Environmental distress in children: Recognizing and responding to eco-anxiety
3
Health system–based clinical pathway improves pediatric lipid screening rates
4
AHA issues 2025 CPR and ECC updates for choking, opioid overdose, and pediatric care
5
